Business and News Update March 2012
Industry news focusing on the people and organizations who work in the clinical trials profession.
Celerion and Ricerca Biosciences Announce "The Biosimilars Alliance"
BioClinica eClinical Suite Chosen by Top BioTech Firm
Quintiles Celebrates 30th Anniversary of Providing Biopharma Solutions
Randomized Controlled Trial Efficacy Quiz Pass Results
ICON Acquires PriceSpective
Randomized Controlled Trial Efficacy Quiz Fail Results
RadSite Expanding On-Site Audit Program to Ensure Compliance with Quality Standards
Site Network Renew with clinicalRSVP.com's Research Participant Registry
CRF Health Launches New ePRO Solution for Data Collection in Late Phase Studies
ePRO Supports Patients, Clinicians, Regulators, and Industry in Oncology
CDISC Broadens Efforts in Europe
Aptuit Completes Sale of CTS to Catalent
MRN Launches Online Training Portal
Clinical Trial Feasibility
Former Synteract CEO Unveils Non-profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
Why Dried Blood Spot Testing Will (Eventually) Make Its Way to the Clinic
WorldCare Clinical Expands Capabilities with Introduction of New Service Offering for Cardiovascular Endpoint Committees
invivodata's DiaryPRO Contributes to Successful NDA for INSYS Therapeutics
CROMSOURCE Adds Early Phase Research Unit to its Portfolio
DaVita Clinical Research Expands in Denver
Impact Corelab to Move to New Corporate Headquarters in Sacramento
FDA Unveils Guidance for Biosimilar Development
The Consented Patient: Quintiles New Digital Patient Unit
Almac Doubles Analytical Capacity in US Headquarters
Craig Lipset on the Recruitment Mind Shift
Patient Recruitment via Social Media: An Uphill Battle
Social Media Patient Recruitment Success Story
Drivers of Patient Interest in Clinical Trial Referral
ClinACE Announces Commencement of CE Mark Registration Trial for a Coronary Stent
